Subgroup analyses showed that using whole flaxseed in doses ≥30 g d-1 , longer-term interventions ( ≥12 weeks ) and studies including participants with higher BMI ( ≥ 27 kg m-2 ) had positive effects on body composition  .
Whole flaxseed is a good choice for weight management particularly for weight reduction in overweight and obese participants
Flaxseed consumption may be inversely associated with obesity ; however , findings of available r and omized controlled trials ( RCTs ) are conflicting .
The present study aim ed to systematic ally review and analyse RCTs assessing the effects of flaxseed consumption on body weight and body composition .
Evaluation of flaxseed formulation as a potential therapeutic agent in mitigation of dyslipidemia
Background : Cardiovascular diseases ( CVDs ) are an increasing health problem all over the world . The search for natural hypolipidemic agents that can be used besides the synthetic drugs is still in its experimental stage . Plant seeds , particularly flaxseed ( Linum usitatissimum ) , which is a rich source of n-3 fatty acids , lignans and phenolic compounds , have also received increasing attention for their potential role in preventing lipid disorders . The present study was undertaken to evaluate the therapeutic potential of flaxseeds in dyslipidemia . Methods : The study included 50 dyslipidemic subjects selected by purposive r and om sampling and were divided into two groups , a control and an experimental group . Both the groups were prescribed similar dietary guidelines . Subjects in the experimental group received 30 g of roasted flaxseed powder for 3 months . Anthropometric parameters , blood pressure , and blood lipid profile were estimated before the study and after completion of the study . Results : Flaxseed supplementation result ed in a remarkable improvement in anthropometric measurements , blood pressure , and lipid profile in the experimental group . Body weight and body mass index ( BMI ) of the experimental group were significantly reduced ( p < 0.01 ) . A lowering of systolic and diastolic blood pressure ( p < 0.05 ) was also recorded in the dyslipidemic subjects . Concomitantly , a highly significant reduction ( p < 0.01 ) in total cholesterol , triglycerides , low density lipoprotein-cholesterol ( LDL-C ) , and very low density lipoprotein-cholesterol ( VLDL-C ) levels , with simultaneous elevation ( p < 0.01 ) in high density lipoprotein-cholesterol ( HDL-C ) levels was observed . Improvement in lipid levels result ed in reduction of atherogenic indices . Conclusions : The supplementation of roasted flaxseed powder for 3 months improved the BMI , blood pressure , and lipid profile of dyslipidemic subjects , thus exhibiting cardio protective effect
Subgroup analyses showed that using whole flaxseed in doses ≥30 g d-1 , longer-term interventions ( ≥12 weeks ) and studies including participants with higher BMI ( ≥ 27 kg m-2 ) had positive effects on body composition  .
Whole flaxseed is a good choice for weight management particularly for weight reduction in overweight and obese participants
Flaxseed consumption may be inversely associated with obesity ; however , findings of available r and omized controlled trials ( RCTs ) are conflicting .
The present study aim ed to systematic ally review and analyse RCTs assessing the effects of flaxseed consumption on body weight and body composition .